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The presence of obstructive CAD was defined as 50%
stenosis in 1 artery as graded by the physician performing
the procedure. A threshold of 50% stenosis was chosen
as the definition of obstructive CAD on the basis of the
American College of Cardiology Foundation and American
Heart Association guidelines, in which a >50% stenosis is a
class IIa recommendation for bypass in patients who undergo
noncoronary cardiac surgery.5 A threshold of 50% was
specifically chosen over the class I recommended threshold
of 70% stenosis on the basis of the goal of designing a
preoperative screening tool. Using the threshold of 50%
ensures that the risk prediction nomogram and the associated
estimated risk for CAD provide a conservative estimate when
being used to triage between CTA and DCA.
Clinical, imaging, and laboratory characteristics were ob-
tained from the time of the DCA by querying the electronic
medical record (Epic, Verona, Wisconsin). Co-morbidities
such as diabetes, hypertension, hyperlipidemia, and stroke
were identified by International Classification of Diseases,
Ninth Revision, coding. Glomerular filtration rate was
calculated using the Cockcroft-Gault equation, and renal
dysfunction was defined as a glomerular filtration rate
<60 ml/min/1.73 m2 or the requirement for renal replacement
therapy. The Institutional Review Board at the Cleveland
Clinic granted approval for this research.
Continuous variables are expressed as mean  SD or as
median (interquartile range) for normal or non-normal
distributions, respectively. Student’s t test or the Wilcoxon
rank sum test was used to assess differences between groups
for continuous variables. Categorical variables were
compared using the chi-square test and are expressed as
percentages. Logistic regression was used to estimate the
odds ratios and 95% confidence intervals (CIs) for predictors
of obstructive CAD. Covariates selected for multivariate
analysis included age, gender, diabetes, hypertension, history
of stroke or transient ischemic attack, smoking, family his-
tory of premature CAD, hyperlipidemia, renal dysfunction,
and the different valve surgical procedures (aortic valve,
mitral valve, tricuspid valve, or multiple valve surgery).
A nomogram to predict the risk for obstructive CAD was
constructed. Patients were randomly split in a 4:1 ratio
into derivation and validation groups. The randomization
was matched by age (5 years) and by gender. Variables
identified by multivariate regression as independent pre-
dictors of obstructive CAD were included in the nomogram.
Within the derivation group, logistic regression was used
to calculate the b coefficients for each of the included
variables. These b coefficients were then applied to the
validation group. The resultant model was validated by
assessing Somers’s D rank correlation between predicted
probabilities and observed responses. Then, bootstrapping
using 250 sample patients was used to penalize for possible
overfitting. This information was also used to estimate C
statistics and corresponding 95% CIs. The performance of
the final model was assessed in the validation cohort and
corrected for overfitting. All analyses were performed using
R version 3.0.2 (R Foundation for Statistical Computing,
Vienna, Austria), and p values <0.05 were considered tol
indicate statistical significance.
Results
We identified 5,360 patients without histories of CAD
who underwent DCA as part of preoperative evaluation for
VHS. Within the cohort, 1,035 patients (19.3%) were found
to have obstructive CAD (Table 1). Compared with patients
without obstructive CAD, those with obstructive CAD
tended to be older, were more frequently male, and had a
higher prevalence of co-morbidities, including diabetes,
hypertension, hyperlipidemia, a history of transient ischemic
attack or stroke, and renal dysfunction. Additionally,
patients with obstructive CAD more often underwent aortic
valve surgery compared with non aortic valve surgery.
Baseline characteristics stratified by specific valve
surgery are listed in Table 2. Within the cohort of patients
who underwent aortic valve surgery, the prevalence of
obstructive CAD was higher in this group compared with
those who underwent mitral, tricuspid, or multiple valve
surgery. Additionally, patients who underwent aortic valve
surgery were older than those who underwent mitral or
tricuspid valve surgery and were more often male.
In univariate analyses, age had the strongest association
with obstructive CAD (Table 3). The relation between age
and obstructive CAD is depicted in Figure 1. As expected,
the risk for obstructive CAD increased with age, but this
relation was not linear. There was a steep increase in risk
Table 1
Baseline characteristics for the Entire cohort and divided According to the
presence or absence of obstructive coronary artery disease
Characteristic Entire
Cohort
(n 5360)
Obstructive CAD p Value
No
(n 4325)
Yes
(n 1035)
Age (years) 63  14 60  13 71  11 <0.001
Male 57% 55% 63% <0.001
Body Mass Index
(kg/m2)
27 [24 30] 27 [24 30] 27 [24 30] 0.20
Diabetes Mellitus 16% 13% 28% <0.001
Hypertension 50% 49% 55% 0.003
History of CVA or TIA 8% 8% 10% 0.04
History of smoking 39% 39% 39% 0.89
Family history of
premature CAD
8% 7% 9% 0.12
Hyperlipidemia 39% 36% 52% <0.001
Renal dysfunction 25% 21% 42% <0.001
Aortic Valve surgery 50% 47% 65% <0.001
Mitral Valve surgery 49% 53% 35% <0.001
Tricuspid Valve surgery 9% 10% 4% <0.001
Multiple Valve surgery 7% 8% 4% <0.001
ACE or ARB 44% 43% 49% <0.001
Aspirin 40% 39% 44% 0.002
Beta blocker 46% 46% 45% 0.38
Statin 35% 32% 46% <0.001
Comorbidities (diabetes, hypertension, hyperlipidemia, history of TIA or
stroke) defined by ICD 9 Code. Renal dysfunction defined as a GFR
<60 mls/min/1.73 m2 or the requirement of renal replacement therapy.
Obstructive CAD defined as 50% stenosis in 1 artery.
Continuous variables expressed as mean  standard deviation or median
[interquartile range].
ACE angiotensin converting enzyme inhibitor; ARB angiotensin
receptor blocker; CAD coronary artery disease, CVA cerebrovascular
accident; TIA transient ischemic attack.
starting at about 50 years of age. The risk for obstructive
CAD in patients 50 years of age was 4.2%, while in pa-
tients >50 years of age, it was 23.0%. The risk for
obstructive CAD further increased with age, and in those
>65 years of age, it reached 32%. In contrast, for patients
40 years of age, the overall risk for obstructive CAD was
only 1.9%.
In addition to the association between obstructive CAD
and age, the univariate analyses identified associations
between obstructive CAD and many traditional CAD risk
factors. These risk factors included male gender, diabetes,
hypertension, hyperlipidemia, and a history of transient
ischemic attack or stroke (Table 3). Aortic valve surgery
was associated with increased odds of obstructive CAD,
whereas mitral valve, tricuspid valve, and multiple valve
surgical procedures were associated with a decreased odds
of obstructive CAD.
In multivariate analyses, age continued to have the
strongest association with obstructive (Table 4). Interest-
ingly, within the multivariate analyses, the specific
dysfunctional valve was not associated with the prevalence
of obstructive CAD. Variables of male gender, diabetes,
hyperlipidemia, family history of premature CAD, and renal
dysfunction remained associated with obstructive CAD.
Hypertension was found to have a negative association with
obstructive CAD. There was no interaction between the
presence of hypertension and age, male gender, or therapy
with aspirin, statin, b blockers, angiotensin-converting
enzyme inhibitors, or angiotensin receptor blockers.
To devise the CAD prediction nomogram, the 5,360-
patient cohort was randomly divided into a 4,286-patient
derivation group and a 1,074-patient validation group.
There were no differences in the baseline characteristics
between these 2 groups (Supplementary Table 1). The
nomogram incorporated age, gender, the presence of
diabetes, hyperlipidemia, renal dysfunction, and a family
history of premature CAD (Figure 2). Hypertension was not
included in the nomogram given its negative association with
obstructive CAD. However, before excluding this variable,
the model was assessed with and without hypertension, and
no statistically significant differences were noted. The
specific valve being operated on was also not included in the
nomogram, as this was not a significant variable in the
Table 2
Baseline characteristics According to valve surgery
Characteristic Aortic Valve
(n 2481)
Mitral Valve
(n 2285)
Tricuspid Valve
(n 200)
Multiple Valve
(n 394)
p Value
Age (years) 64  14 60  12 62  15 65  14 <0.001
Male 61% 57% 34% 42% <0.001
Body Mass Index (kg/m2) 29  6 27  6 28  7 28  7 <0.001
Diabetes Mellitus 21% 10% 18% 22% <0.001
Hypertension 56% 44% 45% 58% <0.001
History of CVA or TIA 9% 7% 7% 15% <0.001
History of smoking 40% 38% 40% 43% 0.07
Family history of premature CAD 8% 8% 7% 6% 0.73
Hyperlipidemia 46% 33% 30% 37% <0.001
Renal dysfunction 25% 21% 37% 40% <0.001
Obstructive CAD 26% 14% 11% 10% <0.001
ACEI or ARB 45% 41.8% 42% 50% 0.01
Aspirin 42% 37% 34% 44% <0.001
Beta blocker 43% 46% 59% 61% <0.001
Statin 42% 29% 25% 34% <0.001
Comorbidities (diabetes, hypertension, hyperlipidemia, history of TIA or stroke) defined by ICD 9 Code. Renal dysfunction defined as a GFR <60 mls/min/
1.73 m2 or the requirement of renal replacement therapy. Obstructive CAD defined as 50% stenosis in 1 artery.
Continuous variables expressed as mean  standard deviation or median [interquartile range].
ACE angiotensin converting enzyme inhibitor; ARB angiotensin receptor blocker; CAD coronary artery disease; CVA cerebrovascular accident;
TIA transient ischemic attack.
Table 3
Univariate predictors of obstructive coronary artery disease
Predictors Or (95% CI) p Value
Age (years) 2.65(2.43 2.89) <0.001
Male 1.38(1.2 1.59) <0.001
Body Mass Index (kg/m2) 1.01(0.95 1.08) 0.72
Diabetes Mellitus 2.49(2.12 2.93) <0.001
Hypertension 1.23(1.08 1.41) 0.003
History of CVA or TIA 1.28(1.02 1.62) 0.03
History of smoking 1.01(0.88 1.16) 0.87
Family history of premature CAD 1.22(0.96 1.56) 0.10
Hyperlipidemia 1.92(1.68 2.21) <0.001
Renal dysfunction 2.75(2.37 3.2) <0.001
Aortic Valve surgery 2.13(1.85 2.45) <0.001
Mitral Valve surgery 0.48(0.42 0.56) <0.001
Tricuspid Valve surgery 0.42(0.3 0.57) <0.001
Multiple Valve surgery 0.45(0.32 0.63) <0.001
ACE or ARB 1.31(1.14 1.5) <0.001
Aspirin 1.24(1.09 1.43) 0.002
Beta blocker 0.94(0.82 1.08) 0.36
Statin 1.82(1.58 2.08) <0.001
Comorbidities (diabetes, hypertension, hyperlipidemia, history of TIA or
stroke) defined by ICD 9 Code. Renal dysfunction defined as a GFR
<60 mls/min/1.73 m2 or the requirement of renal replacement therapy.
Obstructive CAD defined as 50% stenosis in 1 artery.
ACE angiotensin converting enzyme inhibitor; ARB angiotensin
receptor blocker; CAD coronary artery disease; CVA cerebrovascular
accident; TIA transient ischemic attack.
multivariate analysis. Age was separated into 5-year in-
crements and assigned points weighted to corresponding
risk. Male gender and diabetes were assigned 3 points, renal
dysfunction 2 points, and hyperlipidemia and a family his-
tory of premature CAD 1 point. The total score is depicted
on the x axis and the corresponding risk for obstructive CAD
on the y axis. A total score of 13 was associated with a 10%
risk for obstructive CAD.
The final model was first validated for Somers’s D rank
correlation between predicted probabilities and observed
responses. Next, 250 bootstrap samples were used to esti-
mate C statistics and corresponding 95% CIs. The C statistic
for the derivation cohort was 0.766 (95% CI 0.750 to 0.783)
and for the validation cohort 0.767 (95% CI 0.751 to 0.784).
The resulting optimism was 0.004 (95% CI 0.001 to 0.006),
which is sufficiently low to essentially exclude the possi-
bility of overfitting. The bias-corrected C statistic was 0.765
(95% CI 0.748 to 0.782).
Discussion
This study represents the largest evaluation of patients
who underwent preoperative DCA preceding VHS to date. It
was focused on those patients in whom the guidelines
recommend either DCA or coronary CTA for preoperative
coronary assessment. As expected, this study showed
univariate associations between traditional cardiac risk
factors and obstructive CAD. However, in multivariate
analyses, there were no independent associations between
the dysfunctional valve and obstructive CAD. Therefore,
using only age, gender, and the presence or absence of risk
factors, a model was successfully constructed to predict the
risk for obstructive CAD. This model can be used to risk-
stratify patients who undergo preoperative evaluation
before VHS and facilitate triage to the appropriate preop-
erative testing. Before this investigation, there were no
available tools to objectively define risk in this population.
Within the study cohort, the observed prevalence of
obstructive CAD was 19.3%. This prevalence of obstructive
CAD is lower than in cohorts with ischemic symptoms but
concordant with other previous studies of asymptomatic
patients.6 8 In univariate and multivariate analyses, age had
the strongest association with obstructive CAD. The weight
of this association is reflected in the similarities between the
curves seen in Figure 1, in which risk for obstructive CAD is
plotted against age, and Figure 2, in which many traditional
risk factors are included with age.
Figure 1. Risk for obstructive CAD by age.
Table 4
Multivariate analysis of predictors of significant coronary artery disease
Predictors Or (95% CI) p Value
Age (years) 2.41(2.17 2.68) <0.001
Male 1.94(1.64 2.3) <0.001
Body Mass Index (kg/m2) 0.99(0.9 1.08) 0.79
Diabetes Mellitus 2.07(1.7 2.52) <0.001
Hypertension 0.81(0.68 0.97) 0.02
History of CVA or TIA 1.02(0.78 1.34) 0.87
History of smoking 0.98(0.84 1.16) 0.85
Family history of premature CAD 1.34(1.02 1.76) 0.04
Hyperlipidemia 1.47(1.02 2.1) 0.04
Renal dysfunction 1.47(1.21 1.78) <0.001
Aortic Valve surgery 1.36(0.47 3.96) 0.57
Mitral Valve surgery 0.95(0.32 2.77) 0.92
Tricuspid Valve surgery 0.56(0.19 1.63) 0.29
Multiple Valve surgery 0.46(0.13 1.59) 0.22
ACE or ARB 1.16(0.98 1.37) 0.08
Aspirin 0.95(0.81 1.12) 0.55
Beta blocker 0.85(0.72 1) 0.05
Statin 0.91(0.64 1.31) 0.63
Comorbidities (diabetes, hypertension, hyperlipidemia, history of TIA or
stroke) defined by ICD 9 Code. Renal dysfunction defined as a GFR
<60 mls/min/1.73 m2 or the requirement of renal replacement therapy.
Obstructive CAD defined as 50% stenosis in 1 artery.
ACE angiotensin converting enzyme inhibitor; ARB angiotensin
receptor blocker; CAD coronary artery disease; CVA cerebrovascular
accident; TIA transient ischemic attack.
Figure 2. Risk prediction nomogram. The risk for obstructive CAD is
estimated by first calculating a patient’s risk score. The number of points
assigned to the patient’s age is noted at the right of the figure. Male gender
and a history of diabetes are assigned 3 points, renal dysfunction is assigned
2 points, and hyperlipidemia and a family history of CAD are assigned 1
point. The summed total points on the x axis correspond to a predicted risk
for obstructive CAD on the y axis. Five points correspond to a 2% risk for
obstructive CAD, 10 points to a 5% risk, 13 points to a 10% risk, and 15
points to a 17.5% risk. The bias corrected C statistic for the model is 0.765
(95% CI 0.748 to 0.782).
Multiple studies have shown a correlation between
obstructive CAD and aortic valve disease.9 11 This correla-
tion is attributed to similar pathologic processes of coronary
atheroma formation and valvular calcification.12 Conversely,
studies have shown a decreased incidence between mitral
valve disease and obstructive CAD.13 This study showed an
increased incidence of obstructive CAD in patients who
underwent aortic valve surgery and a decreased incidence in
those who underwent mitral valve surgery. However, once
these correlations were evaluated in context of the patient’s
age, they were no longer present. It is possible that the
correlations seen between different valve lesions and
obstructive CAD are the result of different valvular pathol-
ogies’ predilections to present in certain age groups and the
age-dependent nature of coronary atherosclerosis.
The nomogram in Figure 2 can be used to predict the risk
for obstructive CAD in patients who undergo DCA as a part
of a preoperative evaluation for VHS. Using readily acces-
sible information about patient age, gender, and risk factors,
a score can be calculated and cross-referenced with the
curve to assess an estimated incidence of obstructive CAD.
A score of 10 correlates with a 5% risk for obstructive CAD,
while a score of 13 correlates with a 10% risk and a score of
15 with a 17.5% risk. Using this information, it would be
reasonable to consider a patient with a score 13 (i.e., a risk
for obstructive CAD of 10%) to be within the category of
low or intermediate risk and therefore reasonable for coro-
nary CTA instead of DCA.
The recommendation for preoperative coronary evalua-
tion in low- or intermediate-risk patients using coronary CTA
was first introduced in the 2014 version of the guidelines for
valvular heart disease.4,14 By the time this occurred, the
patients in this study had undergone their VHS. However,
had they been prospectively evaluated using the nomogram
from Figure 2, and delegated to CTA if their predicted risk for
obstructive CAD was <10%, 1,501 patients (28%) could
have been triaged to preoperative coronary CTA. The
majority of these patients would have undergone VHS
without the additional risks, inconveniences, and costs of
preoperative DCA. Fewer than 150 patients (2.8% of the
total) would have had positive results on coronary computed
tomography and also required DCA. This is an acceptably
low crossover rate, and given the high sensitivity of coronary
CTA, this approach is very unlikely to result in a patient’s
going to VHS with undiagnosed obstructive CAD.15 Overall,
this approach could result in significant reductions in patient
risk and hospital costs.13
The conclusions of this study must be interpreted within
the context of its limitations. This study was a retrospective
analysis based on a cohort from a single tertiary referral
center. We were unable to determine the type of valve
dysfunction (stenotic vs regurgitant) or the underlying cause
of the valve dysfunction (degenerative, infectious, and so
on). In particular, we were unable to specifically exclude
the patients with functional mitral regurgitation, although
presumably those with ischemic mitral regurgitation would
have been excluded on the basis of a history of CAD. Other
potential limitations include the definition of co-morbidities
on the basis of International Classification of Diseases,
Ninth Revision, codes and a nonadjudicated definition of
obstructive CAD.
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